文献速递冠心病血脂与心血管预防

人类迷走-脾信号转导介导心脏保护

Vago-splenic signal transduction of cardioprotection in humans.
PubMed 文献 · Eur Heart J · 2024-01-01

该研究在健康年轻志愿者、脾切除志愿者及匹配对照中实施远程缺血适应(RIC)或电耳屏刺激(ATS),并将血浆透析液灌注至离体大鼠心脏进行缺血/再灌注。结果发现RIC和ATS均不改变心率及心率变异性,但健康人干预后血浆透析液显著减小大鼠心肌梗死面积,该保护效应在脾切除者及阿托品预处理后消失。

要点

  • RIC和ATS在人类可产生心脏保护性血浆信号,减小离体大鼠心脏梗死面积。
  • 脾脏和迷走神经支配是RIC/ATS心脏保护信号转导的关键环节。
  • 阿托品可消除RIC/ATS诱导的心肌梗死面积减小效应。

核心结论

  • 在人类中,迷走神经支配和脾脏作为中继器官对RIC和ATS的心脏保护信号转导具有决定性作用。

研究设计与样本

  • 研究纳入10名健康年轻志愿者、10名脾切除志愿者和20名匹配对照,实施RIC或ATS,并于干预前后采集静脉血制备血浆透析液,灌注至经历全心缺血/再灌注的离体大鼠心脏。

主要发现

  • RIC或ATS均未改变研究队列的心率和心率变异性。
  • 健康志愿者RIC后血浆透析液使受体大鼠心脏梗死面积(%心室质量)从36±6%(左RIC)降至20±4%,从34±3%(右RIC)降至23±6%。
  • 健康志愿者ATS后血浆透析液使梗死面积从31±5%(左ATS)降至19±4%,从35±5%(右ATS)降至26±9%。
  • 血浆透析液在ATS后4天和RIC后9天仍可减小梗死面积。
  • 在6名健康志愿者亚组中,静脉注射阿托品消除了梗死面积减小效应;脾切除志愿者的梗死面积减小效应也被消除,而20名匹配对照未被消除。

临床怎么用

  • RIC和ATS可能通过迷走-脾通路产生心脏保护性体液信号,但脾切除或迷走神经阻断(如阿托品)可能削弱该保护效应。

局限性

  • 研究样本量较小(健康年轻志愿者10名、脾切除者10名、对照20名),且为实验性离体大鼠心脏模型,临床转化需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The spleen serves as an important relay organ that releases cardioprotective factor(s) upon vagal activation during remote ischaemic conditioning (RIC) in rats and pigs. The translation of these findings to humans was attempted. METHODS: Remote ischaemic conditioning or electrical auricular tragus stimulation (ATS) were performed in 10 healthy young volunteers, 10 volunteers with splenectomy, and 20 matched controls. Venous blood samples were taken before and after RIC/ATS or placebo, and a plasma dialysate was infused into isolated perfused rat hearts subjected to global ischaemia/reperfusion. RESULTS: Neither left nor right RIC or ATS altered heart rate and heart rate variability in the study cohorts. With the plasma dialysate prepared before RIC or ATS, respectively, infarct size (% ventricular mass) in the recipient rat heart was 36 ± 6% (left RIC), 34 ± 3% (right RIC) or 31 ± 5% (left ATS), 35 ± 5% (right ATS), and decreased with the plasma dialysate from healthy volunteers after RIC or ATS to 20 ± 4% (left RIC), 23 ± 6% (right RIC) or to 19 ± 4% (left ATS), 26 ± 9% (right ATS); infarct size was still reduced with plasma dialysate 4 days after ATS and 9 days after RIC. In a subgroup of six healthy volunteers, such infarct size reduction was abrogated by intravenous atropine. Infarct size reduction by RIC or ATS was also abrogated in 10 volunteers with splenectomy, but not in their 20 matched controls. CONCLUSIONS: In humans, vagal innervation and the spleen as a relay organ are decisive for the cardioprotective signal transduction of RIC and ATS.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Lieder HR, Paket U, Skyschally A, et al. Vago-splenic signal transduction of cardioprotection in humans. Eur Heart J. 2024. PMID: 38842545. doi:10.1093/eurheartj/ehae250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。